PATENT CLAIM ANALYSIS

Application Number: 15879260
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "136100"]

Abstract:
The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.

Claim (Index 6):
The method of  claim 5 , wherein said disease is cancer.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 2.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15879040', '14816252', '15501620', '15747385', '14188486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8557838386604398
- 35 USC 102 Novelty (BERT): 0.5829909108779875
- Combined Prediction Score: 0.8285045458821946
- Mean Citation Score: 678.8108719999999
- Max Citation Score: 861.5915
- Similarity Product: 407.5326168078184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test